Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis-Reference-Cited by-同舟云学术

Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis

Published:2016-04-25 Issue:7 Volume:5 Page:1464-1472
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Lisenko Katharina¹,Schönland Stefan O.¹,Jauch Anna²,Andrulis Mindaugas³,Röcken Christoph⁴,Ho Anthony D.¹,Goldschmidt Hartmut¹⁵,Hegenbart Ute¹,Hundemer Michael¹

Affiliation:

1. Department of Internal Medicine V; University of Heidelberg; Heidelberg Germany

2. Institute of Human Genetics; University of Heidelberg; Heidelberg Germany

3. Department of Pathology; University of Heidelberg; Heidelberg Germany

4. Department of Pathology; University Medical Center Schleswig-Holstein; Kiel Germany

5. National Center for Tumor Diseases; University of Heidelberg; Heidelberg Germany

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference31 articles.

1. The classification and typing of amyloid deposits;Gertz;Am. J. Clin. Pathol.,2004

2. The epidemiology of AL and AA amyloidosis;Simms;Baillieres Clin. Rheumatol.,1994

3. Amyloidosis: a clinical overview;Hazenberg;Rheum. Dis. Clin. North Am.,2013

4. The challenge of systemic immunoglobulin light-chain amyloidosis (Al);Palladini;Subcell. Biochem.,2012

5. Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis;Schonland;Bone Marrow Transplant.,2012

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CARDIAC AMYLOIDOSIS: EVOLVING PATHOGENESIS, MULTIMODAL DIAGNOSTICS, AND PRINCIPLES OF TREATMENT;EXCLI J;2023

2. A Review of Cardiac Amyloidosis: Presentation, Diagnosis, and Treatment;Current Problems in Cardiology;2022-12

3. Primary Systemic Amyloidosis With Cardiac and Renal Involvement;Cureus;2022-05-21

4. Monitoring Patients with Light Chain (AL) Amyloidosis during and after Therapy: Response Assessment and Identification of Relapse;Hemato;2022-01-21

5. Treatment in AL Amyloidosis: Moving towards Individualized and Clone-Directed Therapy;Hemato;2021-12-07